|
Volumn 22, Issue 9, 2016, Pages 1111-1117
|
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2016-Executive Summary
a b c d e d f g h i j k l m |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGIST;
AMERICAN COLLEGE OF ENDOCRINOLOGY;
ARTICLE;
HEALTH CARE PERSONNEL;
MEDICAL DECISION MAKING;
ORGANIZATION;
POSTMENOPAUSE OSTEOPOROSIS;
PRACTICE GUIDELINE;
QUESTIONNAIRE;
ANALOGS AND DERIVATIVES;
BLOOD;
BONE DENSITY;
ENDOCRINOLOGY;
EVIDENCE BASED PRACTICE;
HUMAN;
MEDICAL SOCIETY;
ORGANIZATION AND MANAGEMENT;
OSTEOPOROSIS, POSTMENOPAUSAL;
OSTEOPOROTIC FRACTURES;
STANDARDS;
UNITED STATES;
25-HYDROXYVITAMIN D;
BIOLOGICAL MARKER;
COLLAGEN TYPE 1;
PARATHYROID HORMONE;
VITAMIN D;
BIOMARKERS;
BONE DENSITY;
COLLAGEN TYPE I;
ENDOCRINOLOGY;
EVIDENCE-BASED PRACTICE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
OSTEOPOROTIC FRACTURES;
PARATHYROID HORMONE;
SOCIETIES, MEDICAL;
UNITED STATES;
VITAMIN D;
|
EID: 85017327828
PISSN: 1530891X
EISSN: 19342403
Source Type: Journal
DOI: 10.4158/EP161435.ESGL Document Type: Article |
Times cited : (124)
|
References (3)
|